Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.7%

14 terminated out of 102 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

9%

9 trials in Phase 3/4

Results Transparency

21%

9 of 42 completed with results

Key Signals

9 with results75% success14 terminated

Data Visualizations

Phase Distribution

49Total
Not Applicable (14)
P 1 (11)
P 2 (15)
P 3 (6)
P 4 (3)

Trial Status

Completed42
Unknown17
Active Not Recruiting15
Terminated14
Recruiting11
Withdrawn2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 42 completed trials

Clinical Trials (102)

Showing 20 of 20 trials
NCT04387656Active Not RecruitingPrimary

NCI COVID-19 in Cancer Patients, NCCAPS Study

NCT07013474Phase 3RecruitingPrimary

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

NCT07552779Phase 1Completed

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT04491292RecruitingPrimary

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

NCT04500600Active Not RecruitingPrimary

Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

NCT05228275Active Not RecruitingPrimary

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

NCT06194357Not ApplicableCompletedPrimary

Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers

NCT04463758CompletedPrimary

Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

NCT04482647Not ApplicableActive Not RecruitingPrimary

Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic

NCT04551378RecruitingPrimary

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

NCT05672355Phase 2Suspended

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

NCT04565665Phase 1Active Not RecruitingPrimary

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT05102656Not ApplicableActive Not RecruitingPrimary

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

NCT06965751Phase 1Active Not RecruitingPrimary

A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

NCT04169542Recruiting

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

NCT04569851TerminatedPrimary

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

NCT04650178Active Not RecruitingPrimary

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

NCT04474301RecruitingPrimary

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

NCT04447222Active Not RecruitingPrimary

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

NCT05022446RecruitingPrimary

The Impact of COVID-19 on Pulmonary Procedures

Scroll to load more

Research Network

Activity Timeline